Cibus, Inc. (CBUS)
(Delayed Data from NSDQ)
$14.46 USD
-0.36 (-2.43%)
Updated May 31, 2024 04:00 PM ET
After-Market: $14.40 -0.06 (-0.41%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Price, Consensus and EPS Surprise
CBUS 14.46 -0.36(-2.43%)
Will CBUS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for CBUS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CBUS
Cibus (CBUS) Reports Q1 Loss, Tops Revenue Estimates
Cibus (CBUS) Reports Q4 Loss, Tops Revenue Estimates (Revised)
CBUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cibus (CBUS) Reports Q4 Loss, Tops Revenue Estimates
Cibus (CBUS) Moves 6.7% Higher: Will This Strength Last?
Alico (ALCO) Reports Q1 Loss, Tops Revenue Estimates
Other News for CBUS
Cibus’ White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola
Cibus announces successfully made generation edits in Canola
Medifast, Beauty Health among consumer staples additions in Russell Microcap; PLBY Group, Rocky Mountain Chocolate removed
Russell 3000: Veru, Life MD among consumer staple additions; Benson Hill, PetMed Express among deletions
Canada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional Breeding